Advanced or Metastatic Adrenocortical Carcinoma research hub

A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

This study is testing a new drug, DS9051b, for people with advanced adrenal gland cancer or prostate cancer that has spread. Researchers want to see if it's safe, how much to give, and if it shows early signs of working.